Food Sensitivity
Definition and Conceptual Framework
When an individual develops symptoms from eating a food that does not normally cause such symptoms in others, that person is described as having a food sensitivity — sometimes also termed food hypersensitivity. Food sensitivities are divided into different types depending on what body system is involved in the reaction.
The term "food sensitivity" occupies a contested position in the scientific literature, situated between two better-defined entities: food allergy and food intolerance. The medical definitions of the words "sensitivity" and "intolerance" are actively debated in the scientific world and are sometimes loosely applied to food-related reactions. Food sensitivity, food allergy, and food intolerance are all terms used to describe conditions that cause unpleasant symptoms after eating certain foods; of the three, food allergies are the best defined.
In the usage most commonly applied in nutrition and natural-health contexts, food sensitivity refers to a delayed immune-mediated reaction to dietary antigens. Food sensitivities are believed to be caused by an immune reaction primarily driven by IgG, IgA, IgM, and other cell-mediated reactions. The reactive immune responses are characterized as types I, II, III, or IV depending on the mechanism involved; food sensitivity may involve types II, III, or IV, in which more complex sets of immune cells are involved and the response may take between hours and weeks after exposure, and such a response can be chronic in nature.
Distinguishing Food Sensitivity from Food Allergy and Food Intolerance
A true food allergy involves the immune system and is typically driven by immunoglobulin E (IgE) antibodies; allergic reactions usually happen quickly — often within minutes to a few hours after eating a trigger food. A food sensitivity differs from a food allergy in that food sensitivities are linked to an increase in IgG, IgA, and IgM antibodies, whereas food allergies typically elicit IgE reactivity.
Delayed reactions in food sensitivity manifest in many different ways, as they can affect any organ system in the body and can take from 45 minutes to several days for symptoms to become apparent; the delayed onset of symptoms and complex physiological mechanisms involved make food sensitivities especially difficult to identify. Food sensitivities often go undiagnosed or misdiagnosed.
Unlike food sensitivities or food allergies, food intolerances do not involve the immune system; they are digestive problems that cause symptoms in the gut and may be due to the lack of a specific enzyme needed to digest certain foods. Symptoms like bloating, gas, diarrhea, or abdominal cramps tend to develop more gradually, often several hours after eating, and are typically dose-dependent, meaning they worsen with larger quantities of the problematic food.
A further distinction is noted regarding the role of IgG antibodies in sensitivity testing. The American Academy of Allergy, Asthma, and Immunology (AAAAI) states that there is no reliable scientific or medical research demonstrating that IgG antibodies can accurately indicate a food sensitivity or food allergy. The European Academy of Allergy and Clinical Immunology (EAACI) reports that using food sensitivity tests which examine IgG are considered "irrelevant" for the examination of food allergy or intolerance and "should not be performed in case of food-related complaints." These institutional positions highlight the ongoing controversy regarding immunological testing in this area.
Clinical Presentation and Symptoms
Food sensitivities are a non-life-threatening condition with symptoms occurring hours or even days after eating a certain food, and often resolve when the offending food is avoided. With food sensitivity, it is an immune response, but it is a much slower response than an allergy, and it often is due to some sort of imbalance in the gastrointestinal tract.
Symptoms span multiple organ systems and are notably diverse:
- Gastrointestinal: Bloating, abdominal pain, diarrhea, nausea, flatulence, and constipation are among the most commonly reported symptoms.
- Neurological and cognitive: In most cases extra-intestinal symptoms are characterized by vague complaints such as "foggy mind," headache, fatigue, joint and muscle pain, and leg or arm numbness.
- Skin: Flushed skin and related dermatological responses have been reported.
- Musculoskeletal: Joint and muscle pain are reported in extra-intestinal presentations.
- Respiratory: Stuffy or runny nose can occur.
Symptoms may not always be immediate; in fact, it could take up to three days for issues to appear.
Body Systems Involved
Food sensitivity is fundamentally an interaction between the digestive system and the immune system, but its effects extend to numerous other organ systems.
Gastrointestinal System and Gut Barrier
The gut barrier encompasses several interactive, physical, and functional components — the gut microbiota, the mucus layer, the epithelial layer, and the gut mucosal immunity — all of which contribute to homeostasis in a well-regulated manner; this balance might be disrupted by westernized dietary habits, infections, pollution, or exposure to antibiotics, diminishing protective immunity and leading to the onset of chronic diseases.
Compositional and functional alterations to the gut microbiome have been associated with food allergy and related hypersensitivity; increased permeability of the gut barrier allows the translocation of allergenic molecules, triggering Th2 immune responses.
Immune System
IgG-specific antibody-mediated reactions are a body's natural and normal defensive reaction to infiltrating food antigens, which are absorbed into the bloodstream in small quantities; after a meal, food antigens form a complex with antibodies and specific IgG's circulating in the serum. Immune complexes subsequently attach to receptors on red and white blood cells and are then cleared by the liver or spleen (reticuloendothelial system); any circulating immune complexes that are not removed can activate the complement cascade.
Neurological System
Among the most commonly associated autoimmune disorders in NCGS — a prominent model of food sensitivity — are Hashimoto thyroiditis, dermatitis herpetiformis, psoriasis, and rheumatologic diseases; possible neurological involvement is underlined by association with gluten ataxia, gluten neuropathy, and gluten encephalopathy.
Non-Celiac Gluten Sensitivity: A Principal Model of Food Sensitivity
Non-celiac gluten sensitivity (NCGS), also referred to as non-celiac wheat sensitivity (NCWS), represents the most extensively studied model of food sensitivity in the peer-reviewed literature.
NCGS is a clinical syndrome characterized by both intestinal and extra-intestinal symptoms responsive to the withdrawal of gluten-containing food from the diet. NCGS is a term used to describe individuals who are not affected by celiac disease or wheat allergy, yet have intestinal and/or extra-intestinal symptoms related to gluten ingestion with improvement of their symptoms upon withdrawing gluten from their diet.
The prevalence of NCGS has been estimated to be six to ten times higher than that of celiac disease. The pathophysiology of NCGS is largely unclear, and there are contrasting data on the trigger of this condition.
It is important to consider that wheat, in addition to gliadin, contains a number of other potentially bioactive components that may cause gastrointestinal symptoms, such as amylase trypsin inhibitors (ATIs) and fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs). FODMAPs have been postulated as the culprit component for NCGS in wheat, instead of gluten itself.
Among intestinal symptoms, the most frequent in NCGS are bloating, abdominal discomfort and pain, diarrhea, and flatulence; the most common extra-intestinal symptoms were tiredness, headache, and anxiety.
The mechanisms underlying symptom generation in NCGS remain to be fully clarified, although in recent years research has significantly moved forward with new data linking NCGS to changes in gut motility, permeability, and innate immunity.
In the absence of a reliable biomarker, confirmation of an NCGS diagnosis can be made only with a double-blind placebo-controlled (DBPC) gluten challenge; however, this procedure is complex and of limited applicability in routine clinical practice.
NCGS has an immune-related background; there is strong evidence that a selective activation of innate immunity may be the trigger for the NCGS inflammatory response.
The benefits of gluten-free or low-gluten diets in non-celiac-related conditions are limited, and the long-term consequences of this practice may include nutritional and gut microbiota imbalance.
Contributing and Associated Factors
Gut Microbiome Dysbiosis
Increasing evidence suggests that the balance of human gut microbiota and the integrity of the intestinal barrier play roles in the development of food hypersensitivity; environmental factors, including industrialization and consumption of highly processed food, can contribute to altering the gut microbiota and the intestinal barrier, increasing susceptibility to allergic sensitization.
Microbial products such as short-chain fatty acids (SCFAs) reinforce tight-junction integrity and regulate epithelial cytokine responses, whereas dysbiosis and loss of beneficial species may increase the expression of pore-forming proteins like claudin-2, thereby favoring a "leaky gut" that facilitates antigen access to the lamina propria, amplifying Th2 polarization and IgE production.
Since the gut microbiome is constantly changing, food sensitivities sometimes change over time while food allergies generally remain static; food sensitivities are also commonly associated with other GI-related conditions such as leaky gut and irritable bowel syndrome (IBS).
Intestinal Permeability ("Leaky Gut")
The gut barrier is a multi-component system including the gut microbiota, the mucus layer, the epithelial layer, and gut mucosal immunity; all contribute to homeostasis, but this balance might be disrupted by westernized dietary habits, infections, pollution, or exposure to antibiotics, diminishing protective immunity and leading to chronic diseases.
Antibiotic Exposure and Medication Use
Food intolerances have even been linked to taking long courses of antibiotics. More broadly, antibiotic use is recognized as one of the environmental factors capable of disrupting gut microbial composition, which in turn may alter immune tolerance to dietary antigens.
Westernized Dietary Patterns
Consumption of highly processed food can contribute to altering the gut microbiota and the intestinal barrier, increasing the susceptibility to allergic sensitization. The adoption of healthy dietary patterns distinguished by high intake of fruits and vegetables and low intake of sugar and fats (saturated and trans) seems to decrease the risk of non-communicable diseases through its influence on related low-grade inflammation.
Co-Occurring Functional GI Disorders
There appears to be an overlap between NCGS and irritable bowel syndrome (IBS). Differentiation between NCGS and functional gastrointestinal disease — mainly IBS — may be difficult as some of the above-mentioned symptoms overlap with IBS manifestations. It is estimated that in 50–84% of patients with IBS, dietary factors, particularly FODMAPs, play a key role in the development of symptoms.
Nutrients and Natural Ingredients in Relation to Food Sensitivity
Probiotics
Traditional use: Fermented foods containing live microorganisms — such as yogurt, kefir, sauerkraut, miso, and kimchi — have been consumed across diverse traditional food cultures for centuries, with traditional systems attributing digestive and general health benefits to their use.
Scientific evidence: Meta-analysis of data from a total of 26 randomized controlled trials (n = 1,891) indicated that probiotics significantly improved gut barrier function as measured by indicators including diamine oxidase, zonulin, and transepithelial resistance. In murine food allergy models, probiotic administration significantly alleviated allergic symptoms and suppressed the Th2 response, reducing IgE, histamine, and cytokines, while concurrently enhancing regulatory T cell activity and restoring intestinal integrity by upregulating tight junction proteins. In a network meta-analysis of pediatric food allergy, children diagnosed with cow's milk allergy responded more favorably to probiotic interventions compared to those with peanut or mixed-food allergies, and enhanced efficacy of Lactobacillus rhamnosus GG in managing cow's milk allergy-related symptoms was observed.
A systematic review of 51 RCTs indicates that L. rhamnosus provides potential health benefits in various diseases; studies have shown that it may alleviate clinical symptoms of atopic dermatitis in children and modulate gut microbiota to improve symptoms in patients with IBS. Evidence strength: preliminary to moderate for gut barrier support; more robust data exist for specific strains in specific conditions (e.g., cow's milk allergy), while results in other food sensitivity contexts remain variable.
Quercetin
Traditional use: Foods rich in quercetin — including onions, apples, berries, and capers — have long featured in traditional European and Asian dietary practices and folk herbalism. Quercetin-containing herbs such as elder flower and St. John's wort have a history of use in European traditional herbal medicine for inflammatory and respiratory conditions.
Scientific evidence: Quercetin has been extensively studied for its anti-inflammatory, antithrombotic, anti-neurodegenerative, anti-infectious, and immunomodulatory activities; it is one of the most abundant flavonoids in the diet, found in many foods including onions, apples, grapes, berries, citrus fruits, tea, cherries, and broccoli. Research in antibiotic-treated mouse models indicates that quercetin supplementation facilitated probiotic bacterial growth, decreased the inflammatory index to maintain colonic health, and reduced levels of inflammatory markers IFNγ, TNFα, IL-1, and IL-4.
In vitro evidence shows that quercetin enhances the distribution of claudin-1 at intercellular junctions, improving tight-junction assembly responsible for increased transepithelial electrical resistance. These findings are primarily preclinical (animal and cell-based), and well-powered human clinical trials directly examining quercetin's role in food sensitivity are lacking. Evidence in this area is therefore preliminary.
Omega-3 Polyunsaturated Fatty Acids (PUFAs)
Traditional use: Consumption of oily fish and marine mammals has been a cornerstone of traditional diets in Inuit, Japanese, and Mediterranean coastal populations, with associated folk observations of lower inflammatory disease burden.
Scientific evidence: Many nutritive and non-nutritive food components — including n-3 PUFAs — are related in their functions to maintain or improve immune function, including inhibition of pro-inflammatory mediators, promotion of anti-inflammatory functions, modulation of cell-mediated immunity, and alteration of antigen-presenting cell functions; both animal and human studies present promising findings suggesting a clinical benefit of n-3 PUFA in autoimmune and inflammatory disorders. Lipids — particularly polyunsaturated fatty acids compared to saturated fatty acids — differentially affect mucosal inflammation and epithelial protection through absorption pathways. Evidence strength: moderate in broad immunoinflammatory contexts; direct, food-sensitivity-specific clinical trials are limited.
Vitamin D
Traditional use: Vitamin D was not identified as a distinct nutrient until the 20th century; no specific traditional herbal or dietary use targets it. However, traditional diets high in cod liver oil and oily fish (e.g., in Nordic cultures) provided vitamin D as a component of recognized "strengthening" foods.
Scientific evidence: Vitamin D demonstrates measurable benefits in modulating both innate and adaptive immune responses. Key micronutrients such as vitamin D are now recognized as pivotal cofactors; their immunoprotective effects are attributed to mechanisms including antioxidant defense, regulation of inflammatory signaling pathways such as NF-κB and NLRP3 inflammasome, support of epithelial barrier function, and enhancement of T and B cell responses. Evidence strength: well-established for immune modulation broadly; specific randomized trial evidence in food sensitivity per se is limited.
Zinc
Traditional use: Foods rich in zinc — such as oysters, liver, and legumes — have been used in traditional nutrition systems globally as "restorative" or immune-supporting foods during illness, though zinc was not conceptualized in traditional systems as a distinct nutrient.
Scientific evidence: Zinc maintains barrier structure, microbial balance, and immune signaling across intestinal segments. Both animal and human studies present promising findings suggesting a clinical benefit of vitamin D, n-3 PUFA, and green tea catechin EGCG in autoimmune and inflammatory disorders, and vitamin D, vitamin E, zinc, and probiotics in reduction of infection. However, many studies report divergent and discrepant results and conclusions due to various factors; calls for more standardized trial designs, better characterized populations, greater consideration for intervention doses, and more meaningful outcome measurements have been made. Evidence strength: moderate for immune support and barrier maintenance; direct clinical evidence in food sensitivity is limited.
Fermentable Carbohydrates, Prebiotics, and Short-Chain Fatty Acids (SCFAs)
Traditional use: Traditional diets globally incorporated fermented and fiber-rich foods — including Jerusalem artichoke, chicory, garlic, onion, and legumes — which are now recognized as sources of inulin and fructooligosaccharides, functional prebiotic compounds.
Scientific evidence: Fermentable carbohydrates such as inulin and fructooligosaccharides promote microbial fermentation and short-chain fatty acid production — especially butyrate — which strengthens epithelial integrity, stimulates mucus secretion, and regulates immune responses. In probiotic research, increased α-diversity and enrichment of SCFA-producing taxa correlated with elevated acetate, butyrate, and propionate levels and was associated with reduced allergic outcomes. Evidence strength: mechanistically plausible and supported in preclinical and some human microbiome studies; further clinical trials are needed.
Green Tea (EGCG — Epigallocatechin Gallate)
Traditional use: Green tea has been consumed as a medicinal and daily beverage in Chinese, Japanese, and broader East Asian traditional medicine for centuries, valued for anti-inflammatory, digestive, and general health properties. In Chinese medicine, green tea has been used to aid digestion and address gastrointestinal discomfort.
Scientific evidence: Research into EGCG — the predominant catechin in green tea — examines its immunological effects, working mechanisms, and clinical relevance; many of these components are related in their functions to maintain or improve immune function, including inhibition of pro-inflammatory mediators, promotion of anti-inflammatory functions, and modulation of cell-mediated immunity. Both animal and human studies present promising findings for EGCG in autoimmune and inflammatory disorders. Evidence strength: preliminary for direct food sensitivity applications; preclinical and general immunological data are more robust.
Dietary Approaches and Lifestyle Factors
Elimination and Reintroduction Diets
The best-accepted method for diagnosing and confirming food hypersensitivity is empirical, by elimination diet and challenge; this method is laborious and it is difficult to test all the combinations of food types that may be causing problems.
IgG-guided elimination diets have been studied in specific conditions. A growing number of clinical studies — involving IBS, migraine, atopic dermatitis, eosinophilic esophagitis, and autoimmune disorders — report symptomatic improvements following elimination diets tailored to individual IgG reactivity profiles; these findings suggest that, in certain patients, food-specific IgG antibodies may reflect a meaningful immune activation pattern that corresponds to subclinical inflammatory or barrier dysfunction processes.
One randomized, double-blind, sham-controlled trial (published in Gastroenterology, 2025) using an IBS-specific 18-food IgG assay found that subjects on an IgG-guided elimination diet were more likely to achieve the primary endpoint than those on a sham elimination diet; subgroup analysis suggests a more robust benefit for subjects with constipation-predominant IBS and IBS with mixed bowel habits. However, existing evidence remains heterogeneous in quality.
For migraine specifically, clinical evidence has been reported that IgG-positive food elimination diet was beneficial to migraine and its comorbidities and reduced the production of IL-6, TNF-α, and CGRP.
The Low-FODMAP Diet
Since gluten-free grains are lower in fermentable sugars than grains containing gluten, some people who believe they are sensitive to gluten may actually be reacting to FODMAPs; if one has chronic symptoms or food sensitivities, they might benefit from following the systematic elimination process of the low-FODMAP diet. Although strict in the short term, this is not a lifestyle diet; the intent is to isolate food triggers and then reintroduce as many foods as possible.
Mediterranean and Anti-Inflammatory Dietary Patterns
Cross-sectionally, the majority of analyses reported an association between higher diet scores — mostly Mediterranean and anti-inflammatory diet scores — and lower inflammatory markers, with 82 significant associations from 133 analyses; however, using data-driven approaches, only 22 of 145 cross-sectional analyses reported an association between dietary patterns and lower inflammatory markers, with the majority reporting no association. Enriching a low-FODMAP diet with Mediterranean diet components having anti-inflammatory and prebiotic actions may potently optimize the effects of the low-FODMAP diet and eliminate its drawbacks.
Processed Foods and Westernized Diets
Increasing evidence suggests that the balance of human gut microbiota and the integrity of the intestinal barrier play roles in the development of food hypersensitivity; environmental factors, including consumption of highly processed food, can contribute to altering the gut microbiota and the intestinal barrier, increasing the susceptibility to allergic sensitization.
Lifestyle Factors: Stress, Exercise, and Sleep
Lifestyle factors including high stress levels, lack of exercise, and poor dietary habits can also contribute to the development of inflammation and may worsen pre-existing inflammation in the body over time. Modifiable lifestyle factors including diet can affect low-grade inflammation.
Nutritional Adequacy Considerations
Management approaches for food sensitivity should balance dietary modification with recognition of psychological factors while ensuring nutritional adequacy. The adoption of highly restrictive diets without professional guidance may lead to nutritional gaps, particularly when multiple food groups are eliminated simultaneously.
Limitations of Current Evidence
The novelty of the food sensitivity field has generated an expansion of literature data with the unavoidable consequence that some reports are often based on low levels of evidence. Only studies performed on large samples with the inclusion of control groups will be able to clearly establish whether the large body of information from the literature regarding extra-intestinal food sensitivity manifestations can be supported by evidence-based agreement.
Non-celiac gluten sensitivity has gained recognition as a distinct condition, though its pathophysiology remains under investigation. Until causative agents are identified and diagnostic tests developed, NCGS — and, by extension, much of what is termed food sensitivity — remains a diagnosis of exclusion, requiring careful systematic evaluation.
Many studies examining nutrients in immune and food sensitivity contexts report divergent and discrepant results; calls for more standardized trial designs, better-characterized populations, greater consideration for intervention doses, and more meaningful outcome measurements have been made.
References
Go back